Policy and Medicine Compliance Update – November 2023 Issue Features Patient Spokesman, Insulin Costs, SCOTUS Decision, and DOJ Safe Harbor for Mergers and Acquisitions. Read more
Supreme Court Sends Merck’s Fosamax Product Liability Case Back to Appeals Court. Clear Evidence Company Submitted a Label Change to the FDA Read more